How many employees does A1 Pharmaceuticals Holdings Limited have?

A1 Pharmaceuticals Holdings Limited reported an average of 4 employees in the year to 30 Apr 2025.

Is A1 Pharmaceuticals Holdings Limited profitable?

Yes — A1 Pharmaceuticals Holdings Limited reported a profit of £2.7m in the year to 30 Apr 2025.

Company No. 08511438 · Incorporated 30 Apr 2013

A1 Pharmaceuticals Holdings Limited

Registered name: A1 PHARMACEUTICALS HOLDINGS LIMITED

A1 Pharmaceuticals Holdings Limited made £2.7m profit in the year to 30 Apr 2025 (revenue not disclosed).

A1 Pharmaceuticals Holdings Limited reported £2.7m profit in the year to 30 Apr 2025, up 64% on the year before; its revenue was not disclosed. It had 4 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Rainham; we hold 4 years of its filed accounts.

Profit onlySection C · ManufacturingSIC 21100Manufacture of basic pharmaceutical products SIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Rainham, London
Age: 13 yrs · since 2013
Type: Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Latest accounts · year to 30 Apr 2025

Key figures

IndependentSmall team

Revenue

—

Not disclosed in filing

Profit

£2.7m

Growth ▲64.3%

Profit margin

—

Employees

Change 0%

Profit / employee

£665k

Profitable streak

4yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Apr 2022	30 Apr 2023	30 Apr 2024	30 Apr 2025
Disclosure	Profit only	Profit only	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—	—	—
Profit after tax	£3.1m	£2.2m	£1.6m	£2.7m
Profit (best available)	£3.1m	£2.2m	£1.6m	£2.7m
Employees (average)	4	4	4	4
Ratios
Profit margin	—	—	—	—
Profit per employee	£771k	£545k	£405k	£665k
Growth (year on year)
Profit growth	—	▼29.4%	▼25.7%	▲64.3%
Headcount growth	—	0%	0%	0%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.1m	—	—	—
Net assets	£9.1m	£11.1m	£12.6m	£15.1m
Fixed assets	£49k	£49k	£49k	£49k
Current assets	£10.1m	£11.5m	£14.1m	£15.1m
Debtors	£9m	£11.5m	£14.1m	£15.1m
Source	FullAccounts · bulk data Jan 2024	FullAccounts · bulk data Jan 2024	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Oct 2025

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: £665k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲20%; Now £15.1m
Cash at bank: —; Now —
Headcount: 0%; Now 4
Deferred income: —; Now —
Fixed assets: 0%; Now £49k

Corporate ownership

Group structure

Subsidiaries (1)

A1 Pharmaceuticals Public Limited CompanyRev. £60.1m · Profit £2.7m

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Apr 2025 (profit £2.7m), from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.